Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06007404 · ClinicalTrials.gov registry record
Understanding Metabolism and Inflammation Risks for Diabetes in Adolescents
A clinical trial of Obesity and Type 2 Diabetes, sponsored by University of Michigan.
- Recruiting
- Registry status
- 175
- Enrollment target
- 1
- Study location
NCT06007404: Recruiting study of Obesity and Type 2 Diabetes, sponsored by University of Michigan.
NCT06007404 is a study of Obesity and Type 2 Diabetes that is actively recruiting participants, run by University of Michigan. The registered enrollment target is 175 participants, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (79% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06007404, a study of Obesity and Type 2 Diabetes, is actively recruiting participants, sponsored by University of Michigan.
- RECRUITING
- Registry status
- 175 participants
- Enrollment target
- 1
- Study location
Study Summary
This research study collects health-related information and blood samples to better understand how body composition, lifestyle habits, and diet influence meta-inflammatory monocytes (MiMos) in adolescents. The hypothesis of this study is that adolescents at risk for metabolic disease have enhanced MiMo related activities leading to insulin resistance.
Primary Outcome
Plasma Glucose (mg/dL) will be measured prior to, and throughout, an Oral Glucose Tolerance Test (OGTT). Measurements will be taken at baseline (fasting) and 30, 60, 90 and 120 minutes after consumption of glucose dose
Conditions Studied
Study Locations (1)
Michigan
- University of Michigan - Ann Arbor
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 175 participants |
| Start Date | 2023-09-06 |
| Est. Completion | 2027-09 |
What NCT06007404 shows while recruiting
NCT06007404 is an observational study that tracks outcomes without assigning an intervention. The registered 175 participants enrollment target is mid-sized for trials with a published cap, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (79% lower).
The record links to 5 conditions, with Obesity appearing as the primary indexed condition, and to 0 interventions.
NCT06007404 reports a single indexed study location in Michigan.
Frequently Asked Questions
What is clinical trial NCT06007404 about?
NCT06007404 is a clinical study titled "Understanding Metabolism and Inflammation Risks for Diabetes in Adolescents". This research study collects health-related information and blood samples to better understand how body composition, lifestyle habits, and diet influence meta-inflammatory monocytes (MiMos) in adolescents. The hypothesis of this study is that adolescents at risk for metabolic disease have enhanced M...
What is the current status of trial NCT06007404?
This trial is currently recruiting. The enrollment target is 175 participants. The study started on 2023-09-06. Estimated completion is 2027-09.
What conditions does trial NCT06007404 study?
This clinical trial studies the following conditions: Obesity, Type 2 Diabetes, PreDiabetes, Insulin Resistance, Metabolic Disease.
Who is sponsoring clinical trial NCT06007404?
This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06007404 being conducted?
This trial has 1 study location across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Obesity
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06007404's enrollment target sits among peer trials
175 350th of 1053 higher than 704 of 1,053 other Obesity trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Obesity trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
A Hip Flexion Feedback System for Exercise Monitoring in Individuals With Osteoarthritis and Obesity
RECRUITING · Phase 1
-
Metabolic Adaptations to Weight Loss With and Without Exercise
RECRUITING · NA
-
Testing an Integrated PTSD and Weight Management Intervention: A Hybrid Type 1 Trial
RECRUITING · NA
-
TIRzepatide for the Treatment of Obesity in Patients With Atrial Fibrillation
RECRUITING · Phase 2
-
Tirzepatide: Reversal of Lipotoxicity and Adipose Tissue Dysfunction in Humans With Overweight/Obesity
RECRUITING · Phase 2
-
Tai Chi as a Novel Strategy to Increase Physical Activity Among Adults Pursuing Metabolic and Bariatric Surgery
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04722341 · 175 participants · NA
Time-Restricted Eating and Cancer: Clinical Outcomes, Mechanisms, and Moderators
- NCT05094037 · 175 participants · NA
Orthotic Treatment of Diabetic Foot Ulcers
- NCT05165745 · 175 participants · NA
Stick2PrEP Cisgender Women and Trans Individuals
- NCT05312255 · 175 participants · NA
Non-chemotherapeutic Interventions for the Improvement of Quality of Life and Immune Function in Patients With Multiple Myeloma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI